A Study to Assess Bioequivalence of Two Subcutaneous (SC) Formulations of Ocrelizumab in Participants With Multiple Sclerosis (MS)

ClinicalTrials.gov ID: NCT07074886

Public ClinicalTrials.gov record NCT07074886. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

View official ClinicalTrials.gov record → Back to search

ClinicalTrials.gov public records Last synced Apr 28, 2026, 1:52 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Phase II, Randomized, Open-label, Parallel Group, Multicenter Study to Assess Bioequivalence of Two Subcutaneous Formulations of Ocrelizumab in Patients With Multiple Sclerosis

Study identification

NCT ID: NCT07074886
Recruitment status: Recruiting
Study type: Interventional
Phase: Phase 2
Lead sponsor: Hoffmann-La Roche; Industry
Enrollment: 182 participants

Conditions and interventions

Conditions

Multiple Sclerosis

Interventions

Ocrelizumab Reference Formulation Drug
Ocrelizumab Test Formulation Drug

Drug

Eligibility (public fields only)

Age range: 18 Years to 65 Years
Sex: All
Healthy volunteers: Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date: Nov 12, 2025
Primary completion: Jan 30, 2027
Completion: Oct 29, 2030
Last update posted: Apr 26, 2026

2025 – 2030

United States locations

U.S. sites: 9
U.S. states: 8
U.S. cities: 9

Facility	City	State	ZIP	Site status
Profound Research, LLC	Carlsbad	California	92011	Recruiting
Advanced Neurology of Colorado, LLC	Fort Collins	Colorado	80528	Recruiting
Neurology Associates PA	Maitland	Florida	32751	Recruiting
University of South Florida	Tampa	Florida	33612	Recruiting
Johns Hopkins University School Of Medicine	Baltimore	Maryland	21287	Recruiting
University of Massachusetts Medical School	Worcester	Massachusetts	01605	Recruiting
SUNY Upstate Medical University	Syracuse	New York	13210	Recruiting
Hope Neurology	Knoxville	Tennessee	37922	Recruiting
Swedish Medical Center	Seattle	Washington	98104	Recruiting

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 47 non-U.S. sites.

About this trial record page

What this page shows: Public field values for ClinicalTrials.gov record NCT07074886, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do: No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from: Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh: Last update posted Apr 26, 2026 · Synced Apr 28, 2026

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT07074886 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →